Clinical Trial Update: Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes [NA]

View source ↗

Summary

The document notes that a Garvan Institute-sponsored trial on personalized medicine for prediabetes and early type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Garvan Institute of Medical Research | Conditions: Pre Diabetes, Type 2 Diabetes Mellitus | NA | Status: COMPLETED